CoChat

Association of the human bradykinin B2 receptor gene with chronic renal failure

Jozwiak, Lucyna, Drop, Andrzej, Buraczynska, Kinga, Ksiazek, Piotr, Mierzicki, Piotr, Buraczynska, Monika · 2004 · Molecular Diagnosis

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Introduction The kallikrein-kinin system plays an important role in blood pressure homeostasis and renal sodium regulation, and some studies have reported that the kinins have a protective effect against hypertension and the development of renal disease. The B2-bradykinin receptor (B2R) mediates the majority of physiological actions of bradykinin. We investigated the effect of the C181-->T polymorphism in exon 2 of the B2R gene in patients with end-stage renal disease (ESRD).Methods This study involved 790 patients with ESRD and 510 healthy controls. All participants were genotyped for the B2R C181-->T polymorphism by PCR followed by digestion of a PCR product with TaqI restriction endonuclease. DNA fragments were separated by agarose gel electrophoresis. Genotype and allele frequencies were compared between the groups. All calculations were performed using SPSS 5.0 for Windows.Results B2R genotype distribution in patients and controls was in accordance with Hardy-Weinberg equilibrium. The frequency of the T allele was higher in ESRD patients than in controls. The significant difference was observed in the age at onset of renal disease; for patients with the T allele the mean age at onset was 36.8 years, compared with 52.4 years for those carrying only the C allele (p<0.001). The frequencies of the T allele and carrier genotypes were not associated with gender, presence of hypertension, or underlying kidney disease.Conclusion Our results suggest that the B2R polymorphism has a potential role in the earlier development of chronic renal failure in susceptible individuals. We did not confirm the previously published reports that the B2R gene polymorphism has a protective role in the development of ESRD.

Overview

Integrity signals

Registry

Crossref · 10.1007/bf03260059

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 29 references

Cited by

See all 26

Metadata

Authors
Jozwiak, L., Drop, A., Buraczynska, K., Ksiazek, P., Mierzicki, P., & Buraczynska, M.
Affiliations
Medical University of Lublin (PL)
Venue
Molecular Diagnosis
Published
2004-09
Volume
8
Issue
3
Pages
157-161
ISSN
1084-8592 (ISSN-L)
OpenAlex
W2087816099
Cited by
26
References
28
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2023: 1 · 2018: 3 · 2017: 2 · 2016: 2 · 2015: 1 · 2014: 3 · 2012: 2
FWCI
0.37
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Molecular Diagnosis (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Keywords
bradykinin B2 receptor, end-stage renal disease, chronic kidney disease, kallikrein-kinin system, genetic susceptibility, hypertension
MeSH terms
Adult, Exons, Female, Humans, Kidney Failure, Chronic, Male, Polymorphism, Genetic, Kallikrein-Kinin System, Genetic Predisposition to Disease, Receptor, Bradykinin B2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association of the human bradykinin B2 receptor gene with chronic renal failure. https://app.cochat.ai/papers/10.1007/bf03260059
The paper
Jozwiak, L., Drop, A., Buraczynska, K., Ksiazek, P., Mierzicki, P., & Buraczynska, M. (2004). Association of the human bradykinin B2 receptor gene with chronic renal failure. Molecular Diagnosis. https://doi.org/10.1007/bf03260059

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.